0001062993-22-012007.txt : 20220510
0001062993-22-012007.hdr.sgml : 20220510
20220510172642
ACCESSION NUMBER: 0001062993-22-012007
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211220
FILED AS OF DATE: 20220510
DATE AS OF CHANGE: 20220510
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: NELSEN ROBERT
CENTRAL INDEX KEY: 0001219042
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39083
FILM NUMBER: 22911169
MAIL ADDRESS:
STREET 1: 8755 W. HIGGINS ROAD
STREET 2: SUITE 1025
CITY: CHICAGO
STATE: IL
ZIP: 60631
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Vir Biotechnology, Inc.
CENTRAL INDEX KEY: 0001706431
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 812730369
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 499 ILLINOIS STREET
STREET 2: SUITE 500
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
BUSINESS PHONE: 415-906-4324
MAIL ADDRESS:
STREET 1: 499 ILLINOIS STREET
STREET 2: SUITE 500
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
4/A
1
form4a.xml
AMENDED STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0306
4/A
2021-12-20
2021-12-22
0001706431
Vir Biotechnology, Inc.
VIR
0001219042
NELSEN ROBERT
8755 W. HIGGINS ROAD, SUITE 1025
CHICAGO
IL
60631
1
0
1
0
Common Stock
2021-12-20
4
J
0
102041
0
A
247546
D
Distribution of Common Stock held by a limited partnership to its partners for no consideration.
Change from indirect to direct ownership of shares previously reported as beneficially owned by the Reporting Person.
Correction made to include shares previously reported in prior filing on 5/21/21 but not included in the amount of shares beneficially owned in subsequent filings.
By: Robert Nelsen, Managing Director, By: /s/ Mark McDonnell, as Attorney-in-Fact
2022-05-10